Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use
NCT01050062
·
clinicaltrials.gov ↗
COMPLETED
Status
1452
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Telmisartan 80mg
DRUG:
Telmisartan 40mg
DRUG:
Hydrochlorothiazide 12.5mg
Sponsor
Boehringer Ingelheim
Collaborators
[object Object]